Astana Biomed Group, an authorized Abcam distributor in Central Asia

Anti-CTU2/NCS2 antibody [EPR11194] (ab177160)

Key features and details

  • Produced recombinantly (animal-free) for high batch-to-batch consistency and long term security of supply
  • Rabbit monoclonal [EPR11194] to CTU2/NCS2
  • Suitable for: WB, IHC-P, Flow Cyt
  • Reacts with: Human

Overview

  • Product name

    Anti-CTU2/NCS2 antibody [EPR11194]
    See all CTU2/NCS2 primary antibodies

  • Description

    Rabbit monoclonal [EPR11194] to CTU2/NCS2

  • Host species

    Rabbit

  • Tested Applications & Species

    Application Species
    Flow Cyt
    Human
    IHC-P
    Human
    WB
    Human
    See all applications and species data

  • Immunogen

    Synthetic peptide within Human CTU2/NCS2 aa 300-400 (Cysteine residue). The exact sequence is proprietary.
    Database link: Q2VPK5

  • Positive control

    • HT29, K562, HeLa and Human testis lysates. Human colonic carcinoma and kidney tissues. Permeabilized HT29 cells.

  • General notes

     This product was previously labelled as CTU2

     

    This product is a recombinant monoclonal antibody, which offers several advantages including:

    • - High batch-to-batch consistency and reproducibility
    • - Improved sensitivity and specificity
    • - Long-term security of supply
    • - Animal-free production
    For more information see here.

    Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

Properties

  • Form

    Liquid

  • Storage instructions

    Shipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C long term. Avoid freeze / thaw cycle.

  • Storage buffer

    pH: 7.20
    Preservative: 0.01% Sodium azide
    Constituents: 9% PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA, 50% Tissue culture supernatant
  • Concentration information loading...

  • Purity

    Tissue culture supernatant

  • Clonality

    Monoclonal

  • Clone number

    EPR11194

  • Isotype

    IgG

  • Research areas

Images

  • Western blot - Anti-CTU2/NCS2 antibody [EPR11194] (ab177160)
    Western blot - Anti-CTU2/NCS2 antibody [EPR11194] (ab177160)
    All lanes : Anti-CTU2/NCS2 antibody [EPR11194] (ab177160) at 1/1000 dilution

    Lane 1 : HT29 lysate
    Lane 2 : K562 lysate
    Lane 3 : HeLa lysate
    Lane 4 : Human testis lysate

    Lysates/proteins at 10 µg per lane.

    Secondary
    All lanes : Goat anti-rabbit HRP at 1/2000 dilution

    Predicted band size: 56 kDa

  • Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CTU2/NCS2 antibody [EPR11194] (ab177160)
    Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CTU2/NCS2 antibody [EPR11194] (ab177160)

    Immunohistochemical analysis of paraffin-embedded Human kidney tissue labeling CTU2/NCS2 with ab177160 at 1/50 dilution.

    Perform heat mediated antigen retrieval before commencing with IHC staining protocol.

  • Flow Cytometry - Anti-CTU2/NCS2 antibody [EPR11194] (ab177160)
    Flow Cytometry - Anti-CTU2/NCS2 antibody [EPR11194] (ab177160)

    Flow cytometric analysis of permeabilized HT29 cells labeling CTU2/NCS2 with ab177160 at 1/10 dilution (red), or a rabbit IgG (negative) (green).

  • Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CTU2/NCS2 antibody [EPR11194] (ab177160)
    Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CTU2/NCS2 antibody [EPR11194] (ab177160)

    Immunohistochemical analysis of paraffin-embedded Human colonic carcinoma tissue labeling CTU2/NCS2  with ab177160 at 1/50 dilution.

    Perform heat mediated antigen retrieval before commencing with IHC staining protocol.

  • Anti-CTU2/NCS2 antibody [EPR11194] (ab177160)
    Anti-CTU2/NCS2 antibody [EPR11194] (ab177160)

Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES"
For licensing inquiries, please contact partnerships@abcam.com

© 2021 Astana Biomed Group LLP. All rights reserved.